Phase I/II Trial of the Type I Soluble Recombinant Human Interleukin-1 Receptor in HIV-1-Infected Patients
Naoko Takebe(National Cancer Institute), Susan E. Krown(Memorial Sloan Kettering Cancer Center), Josephine Paredes, WILLIAM H. LOWNSBURY, Jan M. Agosti, MICHAEL C. PINO
Cited by 11
Related Papers
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
|New England Journal of Medicine|1996|1.3k
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee.
|Journal of Clinical Oncology|1989|483
Preliminary Observations on the Effect of Recombinant Leukocyte a Interferon in Homosexual Men with Kaposi's Sarcoma
|New England Journal of Medicine|1983|358